4//SEC Filing
Dingivan Christine A 4
Accession 0001440766-09-000001
CIK 0001003124other
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 2:10 PM ET
Size
10.3 KB
Accession
0001440766-09-000001
Insider Transaction Report
Form 4
Dingivan Christine A
EVP/Chief Medical Officer
Transactions
- Award
Stock Options (to buy)
2009-02-18+30,000→ 30,000 totalExercise: $26.64From: 2010-02-18Exp: 2019-02-18→ Common Stock (30,000 underlying)
Holdings
- 7,500
Stock Options (to buy)
Exercise: $20.64From: 2009-11-20Exp: 2018-11-20→ Common Stock (7,500 underlying) - 7,500
Stock Options (to buy)
Exercise: $39.01From: 2009-10-03Exp: 2018-10-03→ Common Stock (7,500 underlying) - 90,000
Stock Options (to buy)
Exercise: $37.93From: 2009-07-28Exp: 2018-07-28→ Common Stock (90,000 underlying)
Footnotes (4)
- [F1]The options will vest in equal increments of 1/3 on February 18, 2010, February 18, 2011 and February 18, 2012.
- [F2]The options will vest in equal increments of 1/3 on November 20, 2009, November 20, 2010 and November 20, 2011.
- [F3]The options will vest in equal increments of 1/3 on October 3, 2009, October 3, 2010 and October 3, 2011.
- [F4]The options vest in equal increments of 1/3 on July 28, 2009, July 28, 2010 and July 28, 2011.
Documents
Issuer
PHARMACEUTICAL PRODUCT DEVELOPMENT INC
CIK 0001003124
Entity typeother
Related Parties
1- filerCIK 0001440766
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 2:10 PM ET
- Size
- 10.3 KB